Search clinical trials for: GSK716155

Total 7 results

GlaxoSmithKline

Completed

A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure

Heart Failure, Congestive

United States, United Kingdom
GlaxoSmithKline

Completed

Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Scintigraphy Study to Assess Gastric Emptying in Healthy Subjects Given GSK716155 or Placebo.

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Japan
GlaxoSmithKline

Completed

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States
GlaxoSmithKline

Completed

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

Diabetes Mellitus, Type 2

United States, Dominican Republic, Chile
GlaxoSmithKline

Completed

Pharmacokinetics/Pharmacodynamics of Albiglutide

Diabetes Mellitus, Type 2

United States

3

Subscribe